BFIC
ARRY

Bedell Frazier Investment Counselling’s Array Biopharma Inc ARRY Stock Holding History

Bedell Frazier Investment Counselling’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-171,321
Closed -$1.16M – 62
2016
Q3 		$1.16M Sell
171,321
-3,100
-2% -$12K 0.48% 35
2016
Q2 		$621K Sell
174,421
-5,800
-3% -$18.9K 0.31% 34
2016
Q1 		$532K Buy
180,221
+1,250
+0.7% +$3.75K 0.27% 34
2015
Q4 		$755K Buy
178,971
+12,050
+7% +$55K 0.37% 36
2015
Q3 		$761K Sell
166,921
-700
-0.4% -$4.15K 0.44% 32
2015
Q2 		$1.21M Sell
167,621
-2,139
-1% -$15.8K 0.48% 41
2015
Q1 		$1.25M Sell
169,760
-3,070
-2% -$21.9K 0.52% 40
2014
Q4 		$817K Buy
172,830
+60,250
+54% +$238K 0.4% 41
2014
Q3 		$402K Buy
112,580
+8,400
+8% +$33.1K 0.19% 48
2014
Q2 		$475K Buy
104,180
+17,880
+21% +$74K 0.24% 41
2014
Q1 		$406K Buy
+86,300
New +$434K 0.23% 43

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Bedell Frazier Investment Counselling's ARRY Position: Q4 2016 in Review

Bedell Frazier Investment Counselling sold out of Array Biopharma Inc (ARRY) in Q4 2016, closing a stake of 171,321 shares — an estimated $1.16M sold.

Bedell Frazier Investment Counselling first reported a position in ARRY in Q1 2014 and held it in 11 quarters. The position peaked at $1.25M in Q1 2015. 167 funds tracked by Wall St. Rank hold ARRY as of Q4 2016.

  • Bedell Frazier Investment Counselling reported no remaining Array Biopharma Inc position as of Q4 2016 after selling out during the quarter.
  • Bedell Frazier Investment Counselling sold 171,321 Array Biopharma Inc shares in Q4 2016, an estimated $1.16M.
  • Bedell Frazier Investment Counselling first reported a position in Array Biopharma Inc in Q1 2014 and held it in 11 quarters.
  • Bedell Frazier Investment Counselling's Array Biopharma Inc position peaked at $1.25M in Q1 2015.
  • 167 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2016.

Based on Bedell Frazier Investment Counselling's 13F filing for Q4 2016, filed 15 Feb 2017.